The CEO of MirimGENE, Professor Jin, gave a presentation on "Sepsis theranostic innovative drug development" at the Acceleration Project in Innovative Drug Development on April 25th.
READ MORE >
1Mirim Jin, CEO of MirimGENE, gave a presentation on the topic of Novel antibody candidate for Rheumatoid Arthritis at the 2023 Korea Drug Development Porject Fund (KDDF) R&D Workshop held in Yeoju. Also, on this day, MirimGENE's poster was designated as an excellent poster.
READ MORE >
source : 세계 최초 바이오마커-CJ도 반한 배지기술에 쏠린 투심 - 팜이데일리 (edaily.co.kr)
READ MORE >
The Korea Drug Development Fund announced the selected research projects for the 3rd National New Drug Development Program in 2022.At this time, the selected projects consist of two areas : “Research on building a new drug R&D ecosystem" and “Clinical development of new drugs," for a total of 26 projects. New drugs developed by MirimGENE and other companies have been selected as gove...
READ MORE >
미림진은 2022년도 제1차 보건의료기술연구개발사업 지원 사업 중 ▲감염예방·치료 기술개발 분야 과제로 선정되었다.
READ MORE >
22일 '2020 데모데이' 온·오프라인 병행 개최 신약개발부터 의료기록 모바일 관리까지 기업 '풍성' source: https://www.hellodd.com/news/articleView.html?idxno=91130
READ MORE >